shareholdersunite.com

Opportunities in smallcaps

shareholdersunite.com header image 2

A Serious Threat Is Emerging To Apollo Endosurgery’s IGB Business

June 6th, 2019 · No Comments

  • After divesting its surgical products, the company has two main businesses left, the ESS and IGB business.
  • We are quite optimistic about their ESS business as the company has just introduced a much better version of its OverStitch.
  • However, its intragastric balloons’ business, good for one-third of revenues could be under threat from competition developing adjustable balloons.
  • Company finances are also pretty bleak.

Source: A Serious Threat Is Emerging To Apollo Endosurgery’s IGB Business – Apollo Endosurgery, Inc. (NASDAQ:APEN) | Seeking Alpha

Tags: APEN